| D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis G Lippi, EJ Favaloro Thrombosis and haemostasis 120 (05), 876-878, 2020 | 753 | 2020 |
| Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. GCM Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A ... N Engl J Med 375 (6), 534-544, 2016 | 511* | 2016 |
| Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre … RD Lopes, RHM Furtado, AVS Macedo, B Bronhara, LP Damiani, ... The Lancet 397 (10291), 2253-2263, 2021 | 478 | 2021 |
| Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial A Gupta, Y Gonzalez-Rojas, E Juarez, MC Casal, J Moya, DR Falci, ... Jama 327 (13), 1236-1246, 2022 | 256 | 2022 |
| Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial E Ramacciotti, LB Agati, D Calderaro, VCR Aguiar, AC Spyropoulos, ... The Lancet 399 (10319), 50-59, 2022 | 245 | 2022 |
| Vein imaging: a new method of near infrared imaging, where a processed image is projected onto the skin for the enhancement of vein treatment RK Miyake, HD Zeman, FH Duarte, R Kikuchi, E Ramacciotti, ... Dermatologic surgery 32 (8), 1031-1038, 2006 | 170 | 2006 |
| Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants D Garcia, YC Barrett, E Ramacciotti, JI Weitz Journal of Thrombosis and Haemostasis 11 (2), 245-252, 2013 | 150 | 2013 |
| ISTH guidelines for antithrombotic treatment in COVID‐19 S Schulman, M Sholzberg, AC Spyropoulos, R Zarychanski, HE Resnick, ... Journal of Thrombosis and Haemostasis 20 (10), 2214-2225, 2022 | 146 | 2022 |
| Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis E Ramacciotti, S Blackburn, AE Hawley, F Vandy, N Ballard-Lipka, ... Clinical and Applied Thrombosis/Hemostasis 17 (4), 425-431, 2011 | 132 | 2011 |
| Leukocyte-and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis E Ramacciotti, AE Hawley, DM Farris, NE Ballard, SK Wrobleski, ... Thrombosis and haemostasis 101 (04), 748-754, 2009 | 128 | 2009 |
| Proteomics of microparticles after deep venous thrombosis E Ramacciotti, AE Hawley, SK Wrobleski, DD Myers Jr, JR Strahler, ... Thrombosis research 125 (6), e269-e274, 2010 | 107 | 2010 |
| Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis E Ramacciotti, N Wolosker, P Puech-Leao, EA Zeratti, PR Gusson, ... Thrombosis research 109 (4), 171-174, 2003 | 76 | 2003 |
| P-selectin/PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis E Ramacciotti, DD Myers Jr, SK Wrobleski, KB Deatrick, FJ Londy, ... Thrombosis research 125 (4), e138-e142, 2010 | 70 | 2010 |
| Evidence-based practical guidance for the antithrombotic management in patients with coronavirus disease (COVID-19) in 2020 E Ramacciotti, AS Macedo, RB Biagioni, RA Caffaro, RD Lopes, ... Clinical and Applied Thrombosis/Hemostasis 26, 1076029620936350, 2020 | 67 | 2020 |
| Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways J Pan, Y Qian, X Zhou, H Lu, E Ramacciotti, L Zhang Journal of Biological Chemistry 285 (30), 22966-22975, 2010 | 63 | 2010 |
| Zika and Chikungunya virus and risk for venous thromboembolism E Ramacciotti, LB Agati, VCR Aguiar, N Wolosker, JC Guerra, ... Clinical and Applied Thrombosis/Hemostasis 25, 1076029618821184, 2019 | 62 | 2019 |
| An update on the pathogenesis of COVID-19 and the reportedly rare thrombotic events following vaccination B Kantarcioglu, O Iqbal, JM Walenga, B Lewis, J Lewis, CA Carter, ... Clinical and Applied Thrombosis/Hemostasis 27, 10760296211021498, 2021 | 59 | 2021 |
| Apixaban versus warfarin for mechanical heart valve thromboprophylaxis in a swine aortic heterotopic valve model PA Lester, DM Coleman, JA Diaz, TO Jackson, AE Hawley, AR Mathues, ... Arteriosclerosis, Thrombosis, and Vascular Biology 37 (5), 942-948, 2017 | 49 | 2017 |
| Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the … FA Orsi, EV De Paula, FO Santos, MM Teruchkin, DHC Campêlo, ... Hematology, transfusion and cell therapy 42, 300-308, 2020 | 48 | 2020 |
| Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups GF Pineo, AS Gallus, GE Raskob, D Chen, LM Ramirez, E Ramacciotti, ... Journal of Thrombosis and Haemostasis 11 (3), 444-451, 2013 | 42 | 2013 |
